Castill Health Announces Plans for Philippines Digital Healthcare Launch, Supported by Craig Astill and Caason Group 
PDF to PPT Converter From Presentations.AI Turns PDFs Into Editable PowerPoint Slide Decks With AI, Keeping Charts, Tables and Images Intact, as a Free-to-Try Gamma and Beautiful.ai Alternative 
Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities Arcutis Completes Enrollment in INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis
A total of 654 adults and children, age six and older, have been enrolled in…
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2022 Financial Results
Management to host conference call and webcast on August 15th at 5:00 pm EDT /…
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
Target enrollment of 180 patients reached in the CERPASS randomized controlled registration-directed clinical trial evaluating…
Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma
– Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance – –…
Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10
Company to host an investor conference call and webcast at 4:30pm ET on that day…
Sunshine Biopharma Files Its Second Quarter Report With the SEC
Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings MONTREAL, Aug….
Apexigen to Participate in the 2022 Wedbush PacGrow Healthcare Conference
SAN CARLOS, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
– Completed enrollment of DISSOLVE II, triggering a $10 million milestone payment obligation from Swedish…
Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates
Transferred anti-IL 18 monoclonal antibody product (AVTX-007) to Apollo Therapeutics in July with the approximate…
XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events
The completion of Regeneron’s acquisition of Checkmate Pharmaceuticals resulted in a $5 million milestone payment…
Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
Completed dose-escalation portion of the ongoing Phase 1 study of NTLA-2001 in patients with transthyretin…
Arbutus Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Key milestones across our chronic hepatitis B virus (cHBV) and pan-coronavirus programs remain on track Financially…
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
– Initiation of Patient Dosing in Multiple Ascending Dose Clinical Trials for DYNE-251 in DMD…
Aleafia Health to Announce Fiscal Year 2023 First Quarter Results
TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
Altimmune to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11
GAITHERSBURG, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
BridgeBio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update
– Reported positive interim Phase 2 data for infigratinib in achondroplasia demonstrating a mean increase…
X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Highlights notable upcoming milestones including data from Phase 1b trial in chronic neutropenia, expected in…
Kraig Biocraft Laboratories Posts Behind the Scenes Look into the Laboratory R&D Processes for Creating Recombinant Spider Silk
ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
Myriad Genetics Reports Second Quarter Financial Results
Highlights: Revenue of $179.3 million for the quarter ended June 30, 2022 Excluding revenue from divested…
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
—Q2 2022 ORLADEYO net revenue of $65.2 million— —FY 2022 ORLADEYO net revenue expected to…